EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Determinant of Prenatal Diagnostic Testing among Women with Increased Risk of Fetal Aneuploidy and Genetic Disorders

Tamandra Morgan, Catherine D Tan, Micaela Della-Torre, Tia Jackson-Bey, Laura DiGiovanni, Christopher A Enakpene

American Journal of Perinatology · 01.03.2024 · 41 (04) · 470-477

DOI: 10.1055/a-1692-0309 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Perinatology, erschienen am 01.03.2024. Verfasst von Tamandra Morgan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of California, San Francisco, San Francisco, California. Hauptthemen laut MEDLINE: Aneuploidy, Down Syndrome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to assess factors that influence patients' decisions in accepting prenatal diagnostic testing following genetic counseling for increased risk of fetal aneuploidy.

Methods

This is a retrospective cohort study of women at increased risk of fetal aneuploidy and genetic disorders who had genetic counseling from January 2012 to December 2016 at a single academic center. Demographics, indications for genetic counseling, and rates of diagnostic testing were collected and compared between those who accepted diagnostic testing and those who chose cell free DNA. The variables were analyzed using Chi-square, Fisher's exact test, and multiple logistic regression.

Result

Of the 2,373 pregnant women who underwent genetic counseling for increased risk of fetal aneuploidy and genetic disorders during the study period, 321 women had diagnostic testing (13.5%). Women at 35 years and older accepted diagnostic testing more than women younger than 35 years (20.7 vs. 11.5%, p < 0.001). Asian women accepted diagnostic testing at 27.7% more than white, non-Hispanic Black, and Hispanic women at 18.0, 12.1, and 11.7%, respectively, p = 0.002. Number of indications for genetic counseling influenced the likelihood of accepting diagnostic testing. Women with one indication had 11.5% acceptance of diagnostic testing, and with two and three indications, it was 17.0 and 29.2%, respectively. The commonest indication for diagnostic testing was cystic hygroma (risk ratio [RR] = 7.5, 95% confidence interval [CI]: 3.12–8.76 p < 0.001). The relative risk of diagnostic testing for fetuses with shortened long bones, femur and humerus, thickened nuchal fold, echogenic bowel, single umbilical artery, and increased nuchal translucency were 4.0, 3.3, 3.1, 2.7, and 2.7, respectively. Abnormal serum analyte alone was associated with less acceptance of diagnostic testing (RR = 0.8, 95% CI: 0.7–0.96, p = 0.017).

Conclusion

Age, race, ethnicity, and cumulative number of indications for genetic counseling influenced acceptance of diagnostic testing in at-risk women of fetal aneuploidy and genetic disorders. Key Points

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AneuploidyDown SyndromePregnancyHumansFemaleRetrospective StudiesNuchal Translucency MeasurementFetusPrenatal DiagnosisUltrasonography, PrenatalGenetic Testing

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, University of California, San Francisco, San Francisco, California.
  • Department of Obstetrics and Gynecology, Advocate Illinois Masonic Medical Center, Chicago, Illinois.
  • Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Beacon Memorial Hospital, South Bend Indiana.
  • Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Mount Sinai School of Medicine, New York, New York.
  • Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, School of Medicine, Texas Tech University Health Sciences Center, Permian Basin, Texas.

Zitieren

APA

Morgan, T., Tan, C. D., Della-Torre, M., Jackson-Bey, T., DiGiovanni, L., & Enakpene, C. A. (2024). Determinant of Prenatal Diagnostic Testing among Women with Increased Risk of Fetal Aneuploidy and Genetic Disorders. American Journal of Perinatology, 41(04), 470-477. https://doi.org/10.1055/a-1692-0309

Vancouver

Morgan T, Tan CD, Della-Torre M, Jackson-Bey T, DiGiovanni L, Enakpene CA. Determinant of Prenatal Diagnostic Testing among Women with Increased Risk of Fetal Aneuploidy and Genetic Disorders. American Journal of Perinatology. 2024;41(04):470-477. doi:10.1055/a-1692-0309

BibTeX
@article{Morgan2024,
  author = {Morgan, Tamandra and Tan, Catherine D and Della-Torre, Micaela and Jackson-Bey, Tia and DiGiovanni, Laura and Enakpene, Christopher A},
  title = {Determinant of Prenatal Diagnostic Testing among Women with Increased Risk of Fetal Aneuploidy and Genetic Disorders},
  journal = {American Journal of Perinatology},
  year = {2024},
  volume = {41},
  number = {04},
  pages = {470--477},
  doi = {10.1055/a-1692-0309}
}
Kostenlos starten →